Activation of Na+/H+ and K+/H+ exchange by calyculin A in Amphiuma tridactylum red blood cells: implications for the control of volume-induced ion flux activity.
Alteration in cell volume of vertebrates results in activation of volume-sensitive ion flux pathways. Fine control of the activity of these pathways enables cells to regulate volume following osmotic perturbation. Protein phosphorylation and dephosphorylation have been reported to play a crucial role in the control of volume-sensitive ion flux pathways. Exposing Amphiuma tridactylu red blood cells (RBCs) to phorbol esters in isotonic medium results in a simultaneous, dose-dependent activation of both Na(+)/H(+) and K(+)/H(+) exchangers. We tested the hypothesis that in Amphiuma RBCs, both shrinkage-induced Na(+)/H(+) exchange and swelling-induced K(+)/H(+) exchange are activated by phosphorylation-dependent reactions. To this end, we assessed the effect of calyculin A, a phosphatase inhibitor, on the activity of the aforementioned exchangers. We found that exposure of Amphiuma RBCs to calyculin-A in isotonic media results in simultaneous, 1-2 orders of magnitude increase in the activity of both K(+)/H(+) and Na(+)/H(+) exchangers. We also demonstrate that, in isotonic media, calyculin A-dependent increases in net Na(+) uptake and K(+) loss are a direct result of phosphatase inhibition and are not dependent on changes in cell volume. Whereas calyculin A exposure in the absence of volume changes results in stimulation of both the Na(+)/H(+) and K(+)/H(+) exchangers, superimposing cell swelling or shrinkage and calyculin A treatment results in selective activation of K(+)/H(+) or Na(+)/H(+) exchange, respectively. We conclude that kinase-dependent reactions are responsible for Na(+)/H(+) and K(+)/H(+) exchange activity, whereas undefined volume-dependent reactions confer specificity and coordinated control.
Ortiz-Acevedo
Alejandro
A
Dept. of Natural Sciences, Univ. of Puerto Rico, Utuado, Puerto Rico 00641. ortizacevedo@yahoo.com
Rigor
Robert R
RR
Maldonado
Hector M
HM
Cala
Peter M
PM
D000584:Amiloride / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D048429:Cell Size / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D004912:Erythrocytes / Q000187:drug effects* / Q000201:enzymology; D008387:Marine Toxins; D009997:Osmotic Pressure; D010080:Oxazoles / Q000494:pharmacology*; D010749:Phosphoprotein Phosphatases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D010766:Phosphorylation; D011188:Potassium / Q000378:metabolism; D027961:Potassium-Hydrogen Antiporters / Q000819:agonists* / Q000378:metabolism; D011494:Protein Kinases / Q000378:metabolism; D012428:Ruthenium / Q000378:metabolism; D012964:Sodium / Q000378:metabolism; D017923:Sodium-Hydrogen Exchangers / Q000819:agonists* / Q000037:antagonists & inhibitors / Q000378:metabolism; D013997:Time Factors; D014562:Caudata / Q000097:blood*
D004791:Enzyme Inhibitors; D008387:Marine Toxins; D010080:Oxazoles; D027961:Potassium-Hydrogen Antiporters; D017923:Sodium-Hydrogen Exchangers; C059041:calyculin A; D000584:Amiloride; D012428:Ruthenium; D012964:Sodium; D011494:Protein Kinases; D010749:Phosphoprotein Phosphatases; D011188:Potassium; C039614:ethylisopropylamiloride
J Cell Physiol. 1996 Jul;168(1):8-17
8647925
Science. 1990 Feb 9;247(4943):723-6
2154036
J Gen Physiol. 1993 May;101(5):733-65
8336103
J Gen Physiol. 1991 Apr;97(4):799-817
1647439
J Biol Chem. 1991 Oct 15;266(29):19166-71
1655777
J Membr Biol. 2000 Sep 15;177(2):159-68
11003690
J Biol Chem. 1994 Mar 25;269(12):8741-8
8132605
Pflugers Arch. 2004 Feb;447(5):549-65
12845533
J Gen Physiol. 1985 May;85(5):649-67
3998706
Am J Physiol. 1999 May;276(5):C1025-37
10329949
J Gen Physiol. 1990 Dec;96(6):1141-52
1962814
Contrib Nephrol. 2006;152:54-104
17065807
J Gen Physiol. 1999 Dec;114(6):743-58
10578012
J Biol Chem. 2001 May 18;276(20):17367-72
11350981
J Gen Physiol. 1991 Nov;98(5):869-80
1662683
J Gen Physiol. 1984 Apr;83(4):497-512
6202824
Cell Biochem Biophys. 2006;45(1):1-18
16679560
Am J Physiol. 1996 Nov;271(5 Pt 1):C1603-11
8944644
Methods Enzymol. 1989;173:330-46
2550728
Am J Physiol. 1993 Jan;264(1 Pt 1):C118-24
8381587
J Gen Physiol. 1980 Dec;76(6):683-708
10822499
Am J Physiol. 1996 May;270(5 Pt 1):C1493-502
8967452
J Gen Physiol. 1990 Jun;95(6):1021-40
2373997
J Biol Chem. 1991 Aug 15;266(23):15406-13
1651331
Biochemistry. 2003 Jun 24;42(24):7448-56
12809501
EMBO J. 1995 Jan 3;14(1):68-75
7828597
Am J Physiol. 1992 Nov;263(5 Pt 1):C917-32
1443104
J Gen Physiol. 1994 Jun;103(6):1035-53
7931136
J Neurosci. 2006 Sep 27;26(39):9944-55
17005858
J Biol Chem. 1992 Nov 25;267(33):23823-8
1331102
Biochemistry. 1997 Oct 21;36(42):12854-61
9335543
Biochemistry. 2006 Feb 21;45(7):2414-24
16475831
J Biol Chem. 1999 Jul 16;274(29):20206-14
10400637
Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12631-6
8901634
J Biol Chem. 2007 Mar 2;282(9):6292-9
17209041
J Physiol. 1994 Oct 1;480 ( Pt 1):1-7
7853214
Biochemistry. 2004 Mar 30;43(12):3628-36
15035633
J Membr Biol. 1996 Jan;149(2):141-59
8834121
J Cell Biol. 2000 Jul 10;150(1):213-24
10893269
Contrib Nephrol. 1998;123:50-78
9761961
Blood Cells Mol Dis. 2001 Jan-Feb;27(1):121-6
11358371
J Biol Chem. 1994 Feb 25;269(8):5583-8
8119893
J Biol Chem. 1994 May 6;269(18):13703-9
8175806
J Gen Physiol. 1987 Aug;90(2):209-27
3655717
J Biol Chem. 1993 Sep 25;268(27):19919-22
7690749
Biochemistry. 1995 Aug 22;34(33):10412-20
7654695
J Exp Biol. 1997 Jan;200(Pt 2):343-52
9050243
Fed Proc. 1985 Jun;44(9):2500-7
3996608
Am J Physiol. 1999 Jun;276(6):C1303-11
10362593